万基遗传(MYGN)
搜索文档
Myriad(MYGN) - 2021 Q3 - Earnings Call Transcript
2021-11-03 09:18
Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2021 Earnings Conference Call November 2, 2021 4:30 PM ET Company Participants Nathan Smith - Senior Vice President, Investor Relations Paul Diaz - President & Chief Executive Officer Bryan Riggsbee - Chief Financial Officer Conference Call Participants Sung Ji Nam - BTIG Puneet Souda - SVB Leerink Matt Sykes - Goldman Sachs Jack Meehan - Nephron Research Rachel Olson - JPMorgan Operator Greetings, and welcome to the Myriad Genetics Third Quarter 2021 Financial Earning ...
Myriad(MYGN) - 2021 Q2 - Earnings Call Transcript
2021-08-04 08:14
Myriad Genetics, Inc. (NASDAQ:MYGN) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET Company Participants Nathan Smith – Senior Vice President-Investor Relations and Treasury Paul Diaz – President and Chief Executive Officer Bryan Riggsbee – Chief Financial Officer Conference Call Participants Sung Ji Nam – BTIG Andrew Cooper – Raymond James Matt Sykes – Goldman Sachs Jack Meehan – Nephron Research Operator Greetings, and welcome to the Myriad Genetics Second Quarter 2021 Earnings Call. During the ...
Myriad(MYGN) - 2021 Q1 - Earnings Call Transcript
2020-11-10 09:16
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2021 Earnings Conference Call November 9, 2020 5:00 PM ET Company Participants Scott Gleason – Senior Vice President of Investor Relations and Corporate Strategy Paul Diaz – President and Chief Executive Officer Bryan Riggsbee – Chief Financial Officer Conference Call Participants Doug Schenkel – Cowen Steve Unger – Needham Tycho Peterson – JPMorgan Puneet Souda – SVB Leerink Derik de Bruin – Bank of America Jack Meehan – Nephron Operator Greetings and welcome to the M ...